These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1755152)

  • 1. Prostatic tissue levels of ofloxacin.
    Aagaard J; Knes J; Madsen PO
    Urology; 1991 Oct; 38(4):380-2. PubMed ID: 1755152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate.
    Chen J; Chen RR; Huang HS
    J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ofloxacin concentration in human prostatic tissue after 3 days of administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jan; 35(1):187-90. PubMed ID: 2729016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurethral prostate resection].
    Botto H; Butreau-Lemaire M; Levy S; Delval C
    Prog Urol; 1993; 3(4):569-75. PubMed ID: 8401617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of norfloxacin in prostatic tissues following oral administration in patients with benign prostatic hyperplasia.
    Netto NR; Palma PC; Srulzon GB; Cortado PL; Fonseca RC
    Int Urol Nephrol; 1988; 20(1):47-9. PubMed ID: 2452139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin.
    Bahk JY; Hyun JS; Lee JY; Kim J; Cho YH; Lee JH; Park JS; Kim MO
    J Urol; 2000 May; 163(5):1560-4. PubMed ID: 10751888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method.
    Claes R; Dusart Y; Dupont JC; Jeanbaptiste B; Podoor M; Douchamps J
    Infection; 1986; 14 Suppl 4():S263-5. PubMed ID: 3469159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients.
    Naber KG; Adam D; Kees F
    Drugs; 1987; 34 Suppl 1():44-50. PubMed ID: 3481328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid.
    Naber KG; Kinzig M; Sörgel F; Weigel D
    Infection; 1993; 21(2):98-100. PubMed ID: 8491527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of oral ofloxacin in 3-day therapy for transurethral resection of the prostate].
    Morita M; Ito S; Suzuki K
    Hinyokika Kiyo; 1992 Jul; 38(7):869-74. PubMed ID: 1381870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis].
    Suzuki K; Tamai H; Naide Y; Ando K; Moriguchi R
    Hinyokika Kiyo; 1984 Oct; 30(10):1505-18. PubMed ID: 6596877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the concentration of cefminox sodium in serum and prostatic tissue].
    Sasagawa I
    Hinyokika Kiyo; 1990 Jun; 36(6):737-9. PubMed ID: 1700586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.